Astorg Partners has acquired the global microbiology business of Thermo Fisher Scientific for $1.075 billion, consisting of cash and a $50 million seller note, carving out a maker of diagnostic test media and equipment as a standalone company.
The microbiology unit makes the consumables and instruments that laboratories use to grow, identify and test microbes — the bacteria and fungi behind infections, food contamination and drug-manufacturing risks. Its core products are culture media (the n...
Continue Reading
Sign up for FREE to read the full article and access 150K+ alternative investment headlines.
Alternative Investment News